EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Comorbidity Burden in Severe and Nonsevere Asthma: A Nationwide Observational Study (FINASTHMA)

Hannu Kankaanranta, Arja Viinanen, Pinja Ilmarinen, Hanna Hisinger-Mölkänen, Juha Mehtälä, Tero Ylisaukko-Oja, Juhana J Idänpään-Heikkilä, Lauri Lehtimäki

The Journal of Allergy and Clinical Immunology: In Practice · 2024-01 · 12 (1) · 135-145.e9

DOI: 10.1016/j.jaip.2023.09.034 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024-01. Verfasst von Hannu Kankaanranta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenbur…. Hauptthemen laut MEDLINE: Anti-Asthmatic Agents, Atrial Fibrillation, Asthma, Osteoporosis. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GlaxoSmithKline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Asthmatic AgentsAtrial FibrillationAsthmaOsteoporosisHeart FailurePneumoniaAdultHumansCross-Sectional StudiesComorbidityAdrenal Cortex HormonesObesityAdministration, Inhalation

Stichwörter der Autor:innen

Cardiac diseaseCataractComorbiditiesCorticosteroidsHealth care resource useOsteoporosisPneumoniaSevere asthmaType 2 diabetes

Substanzen

Anti-Asthmatic AgentsAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Respiratory Medicine, Seinäjoki C…
  • Pulmonary Diseases and Clinical Allergology, Turku University Hospital, Turku, Finland; Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland.
  • GlaxoSmithKline (GSK) Oy, Espoo, Finland.
  • Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • MedEngine Oy, Helsinki, Finland.
  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Allergy Centre, Tampere University Hospital, Tampere, Finland.

Förderung

  • GlaxoSmithKline

Zitieren

APA

Kankaanranta, H., Viinanen, A., Ilmarinen, P., Hisinger-Mölkänen, H., Mehtälä, J., Ylisaukko-Oja, T., Idänpään-Heikkilä, J. J., & Lehtimäki, L. (2024). Comorbidity Burden in Severe and Nonsevere Asthma: A Nationwide Observational Study (FINASTHMA). The Journal of Allergy and Clinical Immunology: In Practice, 12(1), 135-145.e9. https://doi.org/10.1016/j.jaip.2023.09.034

Vancouver

Kankaanranta H, Viinanen A, Ilmarinen P, Hisinger-Mölkänen H, Mehtälä J, Ylisaukko-Oja T, et al. Comorbidity Burden in Severe and Nonsevere Asthma: A Nationwide Observational Study (FINASTHMA). The Journal of Allergy and Clinical Immunology: In Practice. 2024;12(1):135-145.e9. doi:10.1016/j.jaip.2023.09.034

BibTeX
@article{Kankaanranta2024,
  author = {Kankaanranta, Hannu and Viinanen, Arja and Ilmarinen, Pinja and Hisinger-Mölkänen, Hanna and Mehtälä, Juha and Ylisaukko-Oja, Tero and Idänpään-Heikkilä, Juhana J and Lehtimäki, Lauri},
  title = {Comorbidity Burden in Severe and Nonsevere Asthma: A Nationwide Observational Study (FINASTHMA)},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2024},
  volume = {12},
  number = {1},
  pages = {135--145.e9},
  doi = {10.1016/j.jaip.2023.09.034}
}
Kostenlos starten →